Data and Reports

Data and reports for HIV/AIDS, Sexually Transmitted Diseases (STDs), and Hepatitis can be accessed on this page.  Many data include a combination as the burden of these infections is related.

If you cannot find the information  you wish to access on this page, information for data requests can also be found on this page.  Please note the following information, however, before making a data request:

  • If you are with the media please contact Public Relations.
  • Data requests made through DDP can only be may for chlamydia, gonorrhea, syphilis, and HIV data.  DDP does not handle data requests for other health subjects.  For other data and data requests, please visit the VDH data portal.

National Resources

  • Atlas: CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (NCHHSTP) interactive tool allowing users to create maps, charts and tables using nationwide HIV/AIDS and STD surveillance data
  • AIDSVu: Interactive online map of HIV prevalence developed by the Rollins School of Public Health at Emory University of the Richmond Metropolitan Statistical Area (MSA) and Hampton Roads
  • CDC’s Division of STD Prevention Annual Statistics
  • HepVu:  Interactive online maps that visualize the Hepatitis C epidemic across the country.

Virginia Data

HIV/AIDS Annual Reports

HIV Epidemiology Profile

2020 Updates:

2019 Updates:

2018 Updates:

2016 Virginia HIV Epidemiologic Profile

HIV Continuum of Care

Virginia’s 2020 HIV Continuum of Care (HCC) is a framework used to monitor health outcomes of persons living with HIV in Virginia from initial diagnosis to viral suppression. The 2020 HCC below presents these definitions:

  • Care marker: a "care marker" is defined as a CD4, viral load, or genotype testing lab, an HIV medical care visit, or an antiretroviral (ART) prescription; these are considered markers for evidence of HIV care
  • Persons living with HIV as of 12/31/2020: the number of persons aware of their status, diagnosed and living with HIV with a last known residence in Virginia as of 12/31/2020
  • Newly diagnosed and linked to HIV care within 30 days: persons newly diagnosed in Virginia in 2020 and linked to HIV care within 30 days from initial diagnosis
  • Evidence of HIV care in 2020: persons living with HIV as of 12/31/2020 who had at least one care marker in calendar year (CY) 2020
  • Retained in HIV care in 2020: persons living with HIV as of 12/31/2020 who had at least two care markers at least 3 months (90 days) apart in CY 2020
  • Virally suppressed in 2020: persons living with HIV as of 12/31/2020 with their most recent viral load in CY 2020 measuring at <200 copies/milliliter (mL)

All data presented for Virginia’s 2020 HCC comes from the Care Markers Database within the Division of Disease Prevention.  Data are reported as of December 2020 and accessed May 2021.  Data are still considered preliminary.

VA Medication Assistance Program Updates

Maps

Virginia Hepatitis C Epidemiological Profile

Please follow the instructions below for requesting information related to morbidity reports of HIV/AIDS/STDs in Virginia.


Important Notes Regarding HIV and STD Data Requests:

  • It is important to note that HIV data is not final until 12 months following diagnosis date. Data on sexually transmitted diseases (STD; chlamydia, gonorrhea, syphilis) are considered complete in May following the close of the year.
  • To maintain confidentiality, suppression may be warranted for certain data where population size and/or number of cases are too small to report. Zip codes in Virginia are subject to change over time; therefore, requests for number of cases or rates by zip code may not be an accurate geographic unit of measure.
  • Rates for a partial year of data are not calculated.
  • Requests for data below the county level must be reviewed by DDP management and approved on a case-by-case basis. Data requests that are especially complex may be subject to the conditions of the Freedom of Information Act (FOIA) and a charge for staff time may be warranted. Data to be used for research purposes may require review by the VDH Institutional Review Board (IRB).

Last Updated: August 31, 2021.